MBNL1 and breast carcinoma: In contrast, when MBNL1-AS1 was knocked down, the tumor growth was faster than that in the control group, which was consistent with the trend observed in vitro (Figure 4d,f), suggesting that MBNL1-AS1 could hinder breast cancer growth in vivo.